Safety and antiviral effect of a triple combination of HIV-1 broadly neutralizing antibodies: a phase 1/2a trial
Most Cited Paper
in HIV Research and Treatment
18 Months Post-Publication
Class of 2026
“Safety and antiviral effect of a triple combination of HIV-1 broadly neutralizing antibodies: a phase 1/2a trial”
A research intelligence initiative by Pepkio
pri.pepkio.com/top-papers/hiv-research-and-treatment/2026/
Topics
Broadly neutralizing antibodies (bNAbs) · PGT121 · PGDM1400 · VRC07-523LS · triple bNAb combination · Treatment interruption · HIV viral suppression · Viral rebound · bNAb resistance mutations · baseline resistance · immune activation · T cell exhaustion · proinflammatory signaling · CD4 count · serum bNAb concentrations · neutralization coverage · viral escape
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited HIV Research and Treatment Papers, Class of 2026. https://pri.pepkio.com/top-papers/hiv-research-and-treatment/2026. Accessed 2026-07-21. Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459